Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1278940

Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future


Pouliquen, Daniel; Gall Trošelj, Koraljka; John Anto, Ruby
Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future // Pharmaceutics, 15 (2023), 6; 1612, 31 doi:10.3390/pharmaceutics15061612 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 1278940 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future

Autori
Pouliquen, Daniel ; Gall Trošelj, Koraljka ; John Anto, Ruby

Izvornik
Pharmaceutics (1999-4923) 15 (2023), 6; 1612, 31

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
curcuminoids ; curcumin ; cancer ; signaling pathways ; metabolic reprogramming ; chemosensitization

Sažetak
: The number of published studies on curcuminoids in cancer research, including its lead molecule curcumin and synthetic analogs, has been increasing substantially during the past two decades. Insights on the diversity of inhibitory effects they have produced on a multitude of pathways involved in carcinogenesis and tumor progression have been provided. As this wealth of data was obtained in settings of various experimental and clinical data, this review first aimed at presenting a chronology of discoveries and an update on their complex in vivo effects. Secondly, there are many interesting questions linked to their pleiotropic effects. One of them, a growing research topic, relates to their ability to modulate metabolic reprogramming. This review will also cover the use of curcuminoids as chemosensitizing molecules that can be combined with several anticancer drugs to reverse the phenomenon of multidrug resistance. Finally, current investigations in these three complementary research fields raise several important questions that will be put among the prospects for the future research related to the importance of these molecules in cancer research.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Farmacija



POVEZANOST RADA


Ustanove:
Institut "Ruđer Bošković", Zagreb

Profili:

Avatar Url Koraljka Gall Trošelj (autor)

Poveznice na cjeloviti tekst rada:

doi www.mdpi.com

Citiraj ovu publikaciju:

Pouliquen, Daniel; Gall Trošelj, Koraljka; John Anto, Ruby
Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future // Pharmaceutics, 15 (2023), 6; 1612, 31 doi:10.3390/pharmaceutics15061612 (međunarodna recenzija, pregledni rad, znanstveni)
Pouliquen, D., Gall Trošelj, K. & John Anto, R. (2023) Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future. Pharmaceutics, 15 (6), 1612, 31 doi:10.3390/pharmaceutics15061612.
@article{article, author = {Pouliquen, Daniel and Gall Tro\v{s}elj, Koraljka and John Anto, Ruby}, year = {2023}, pages = {31}, DOI = {10.3390/pharmaceutics15061612}, chapter = {1612}, keywords = {curcuminoids, curcumin, cancer, signaling pathways, metabolic reprogramming, chemosensitization}, journal = {Pharmaceutics}, doi = {10.3390/pharmaceutics15061612}, volume = {15}, number = {6}, issn = {1999-4923}, title = {Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future}, keyword = {curcuminoids, curcumin, cancer, signaling pathways, metabolic reprogramming, chemosensitization}, chapternumber = {1612} }
@article{article, author = {Pouliquen, Daniel and Gall Tro\v{s}elj, Koraljka and John Anto, Ruby}, year = {2023}, pages = {31}, DOI = {10.3390/pharmaceutics15061612}, chapter = {1612}, keywords = {curcuminoids, curcumin, cancer, signaling pathways, metabolic reprogramming, chemosensitization}, journal = {Pharmaceutics}, doi = {10.3390/pharmaceutics15061612}, volume = {15}, number = {6}, issn = {1999-4923}, title = {Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future}, keyword = {curcuminoids, curcumin, cancer, signaling pathways, metabolic reprogramming, chemosensitization}, chapternumber = {1612} }

Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font